Press Release: Coriolis Pharma : Coriolis Pharma Launches New U.S. Entity and Platform Services
Coriolis Pharma, a biopharma company specializing in R&D and GMP drug product development, recently announced the launch of a new U.S. entity and two novel platform services designed to accelerate and de-risk the development of antibody drug candidates.
Read full article »
Coriolis is a Germany-based CRO that provides services such as product formulation and process development for the biopharmaceutical industry.
Read more